These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 3006712)
1. Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals. Hosoki K; Takeyama K; Minato H; Fukuya F; Kawahara S; Kadokawa T Arzneimittelforschung; 1986; 36(1):77-83. PubMed ID: 3006712 [TBL] [Abstract][Full Text] [Related]
2. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals. Takeyama K; Minato H; Nakatsuji K; Suzuki H; Nose I; Oka M; Hosoki K; Hatano N; Kadokawa T Arzneimittelforschung; 1986; 36(1):69-73. PubMed ID: 3513779 [TBL] [Abstract][Full Text] [Related]
3. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs. Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389 [TBL] [Abstract][Full Text] [Related]
4. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs. Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390 [TBL] [Abstract][Full Text] [Related]
5. Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats. Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Laitinen LA; Manninen V; Ylitalo P; Vapaatalo H Scand J Urol Nephrol Suppl; 1984; 79():23-7. PubMed ID: 6089314 [TBL] [Abstract][Full Text] [Related]
6. Effect of captopril on urinary excretion of prostaglandins and renin-angiotensin-aldosterone system in normal subjects. Zacharieva S; Koev D; Andonova K Acta Physiol Pharmacol Bulg; 1989; 15(4):25-30. PubMed ID: 2699540 [TBL] [Abstract][Full Text] [Related]
7. Tissue levels, tissue angiotensin converting enzyme inhibition and antihypertensive effect of the novel antihypertensive agent alacepril in renal hypertensive rats. Nambu K; Matsumoto K; Takeyama K; Hosoki K; Miyazaki H; Hashimoto M Arzneimittelforschung; 1986; 36(1):47-51. PubMed ID: 3006710 [TBL] [Abstract][Full Text] [Related]
8. Acute effects of the new oral angiotensin converting enzyme inhibitor 1-(D-3-acetylthio-2-methylpropanoyl)-L-prolyl-L-phenylalanine (Alacepril) in essential hypertension. Mizuno K; Hashimoto S; Kunii N; Tani M; Niimura S; Yabe R; Watari H; Fukuchi S Res Commun Chem Pathol Pharmacol; 1985 Aug; 49(2):175-87. PubMed ID: 2997886 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiotensin-converting enzyme with quinapril (CI-906): investigation of antihypertensive mechanisms in spontaneously hypertensive rats. Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Metsä-Ketelä T; Tuomisto L; Manninen V; Vapaatalo H J Pharmacol Exp Ther; 1986 Apr; 237(1):246-51. PubMed ID: 3007740 [TBL] [Abstract][Full Text] [Related]
10. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems. Ohman KP; Karlberg BE; Nilsson OR; Wettre S Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190 [TBL] [Abstract][Full Text] [Related]
11. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems. Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807 [TBL] [Abstract][Full Text] [Related]
12. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs. McCaa RE; Gillespie JB Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226 [TBL] [Abstract][Full Text] [Related]
13. Effects of captopril on the urinary excretion of prostanoids and kallikrein in spontaneously hypertensive rats. Säynävälammi P Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):285-90. PubMed ID: 3541494 [TBL] [Abstract][Full Text] [Related]
14. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives. Iimura O; Shimamoto K Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450 [TBL] [Abstract][Full Text] [Related]
15. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood. Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777 [TBL] [Abstract][Full Text] [Related]
16. Role of the renin-angiotensin-aldosterone and kallikrein-kinin systems in the control of fluid and electrolyte metabolism, renal function, and arterial blood pressure. McCaa RE Clin Exp Hypertens A; 1982; 4(9-10):1593-611. PubMed ID: 6754146 [TBL] [Abstract][Full Text] [Related]
17. Antihypertensive mechanism of alacepril: effect on norepinephrine-induced vasoconstrictive response in vitro and in vivo. Takeyama K; Minato H; Ikeno A; Hosoki K; Kadokawa T Arzneimittelforschung; 1986; 36(1):74-7. PubMed ID: 3513780 [TBL] [Abstract][Full Text] [Related]
18. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension. Ideishi M; Sasaguri M; Ikeda M; Arakawa K Clin Ther; 1989; 11(4):441-51. PubMed ID: 2550133 [TBL] [Abstract][Full Text] [Related]
19. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system. Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244 [TBL] [Abstract][Full Text] [Related]
20. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension]. Marzecka J Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]